Financing ·
LifeStance Health Group, Inc. entered into an underwriting agreement on September 9, 2026, for the offering of…
LFSTLifeStance Health Group, Inc.
LifeStance Health Group, Inc. entered into an underwriting agreement on September 9, 2026, for the offering of 22,250,000 shares of common stock by selling stockholders. The company agreed to purchase 2,000,000 of these shares from the underwriter at the same price paid by the underwriter to the sellers. Barclays Capital Inc. served as the underwriter. The closing occurred on September 11, 2026. LifeStance Health Group did not receive any proceeds from this transaction. The company operates in the healthcare industry, providing mental health and behavioral health services.